ERIC THOMAS SCHMIDT - 23 Mar 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role: Chief Financial Officer
Signature: /s/ Veer Bhavnagri, Attorney-in-Fact for Eric Schmidt
Issuer symbol: ALLO
Transactions as of: 23 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 25 Mar 2022, 17:49:56 UTC
Previous filing: 17 Mar 2022
Next filing: 17 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALLO	Common Stock	Award	$0	+237,358	+236%	$0.000000	337,904	23 Mar 2022	Direct
holding	ALLO	Common Stock						1,152,595	23 Mar 2022	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALLO	Stock Option (Right to Buy)	Award	$0	+368,589		$0.000000	368,589	23 Mar 2022	Common Stock	368,589	$9.69	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter
F2	The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.